This article was originally published on FDLI. Introduction China’s drug market has exploded over the last few years, and future growth is estimated at 6-7% over the next five years. Valued at about $140 billion, it is now the second-largest drug market... Read More
As health care firms in China and Hong Kong race to respond to the challenges of the global COVID-19 pandemic, they are experiencing sustained investment (mostly from China funds and wealthy Chinese investors), and are benefiting from recent regulatory changes and technological... Read More
This article was originally published on MedTech Intelligence. For the past several years, the companion technologies, which allow users to mirror reality, have been emerging as strong players in the medical field in Asia and beyond, given their potential to simulate surgery,... Read More
More cancer patients are being diagnosed in China than in any other global market in the world. Cancer is rampant in China due to a number of factors including an aging population, smoking, air pollution, as well as other poor lifestyle choices.... Read More
As the use of artificial intelligence (AI) takes hold in Asia’s healthcare industry, researchers are collecting detailed health profiles of citizens and using the data to test treatments, monitor adverse drug reactions in patients, detect the risk of cognitive issues in children... Read More
Driven by the needs of its growing number of aging adults, the Japanese healthcare industry is rapidly adopting digital technology to bolster the work of physicians, nurses and medical researchers. Increasingly, Japanese doctors are digitizing medical records and consolidating metadata health data... Read More
This article was originally published on MedTech Intelligence. The use of artificial intelligence in healthcare is accelerating rapidly, as devices and products that mimic human learning and behavior are on track to get regulatory approval in the United States, Europe and increasingly,... Read More
The coronavirus will affect the medical supply chain coming from China. Various reports indicate that while 50% of Chinese factories are now open, only about half of these are actually producing medical products. Many Chinese employees are still working from home. While... Read More
With the COVID-19 virus shaking global markets and economies, anti-viral drug developers around the world are increasing efforts to develop treatments for the disease. Western pharmaceutical firms and research organizations have launched accelerated research and testing programs for novel coronavirus vaccines. Among... Read More
With the incidence of non-communicable diseases rising in Malaysia and as household incomes grow, the Southeast Asian nation presents fertile ground for both the pharmaceutical and medical device industries. According to analyst GlobalData, the medical device market in the country, worth $1.28... Read More